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Abstract 
Critical limb ischemia (CLI), the most advanced clinical manifestation of peripheral arterial 
disease (PAD), is associated with cycles of ischemia and reperfusion (I/R) that are thought to 
compromise the bioenergetics of mitochondria. However, the specific biochemical mechanism 
through which the mitochondrial dysfunctions occur have not been fully characterized. In this 
experiment, the left femoral arteries of mice (n=3) were ligated and excised, and tibial anterior 
muscles were harvested on day 7 and 14. The sections were stained for hematoxylin and eosin 
(H&E), succinate dehydrogenase (SDH), and cytochrome C oxidase (COX). The results show 
significant increase in centralized nuclei in injured muscles compared to contralateral controls. 
SDH and COX data were inconclusive. Future studies are expected to continue identifying key 
mechanisms that link oxidative damage and mitochondrial dysfunction to develop targeted 
therapies that aim to improve the compromised bioenergetics of mitochondria, improving the 
prognosis of PAD and CLI patients. 
 
Introduction 
Peripheral Arterial Disease (PAD) is usually caused by atherosclerotic occlusive disease, where 
an artery develops a plaque that eventually blocks the circulation of blood1. While the disease is 
uncommon among population under the age of 50, it is estimated to affect more than 25% of the 
population over the age of 802. The most severe cases of PAD, known as critical limb ischemia 
(CLI), are associated with 20% mortality rate at 1 year, and may require amputation among other 
surgeries1,3,4. There has been research performed to treat the symptoms through surgeries, physical 
therapies, and other walking regimens, but little is known about the exact mechanism and early 
progression of PAD5.  
In patients with PAD, the hypoxia induced by reduced blood flow results in ischemic muscle 
injuries, leading to muscle degeneration and the associated clinical symptoms6,7. An increasing 
number of researches have started to point to defective bioenergetics of mitochondria as an 
additional source of myopathy8-11. PAD patients undergo cycles of ischemia and reperfusion (I/R) 
where the blood flow is occluded during ischemia and reperfusion occurs when elevation of blood 
pressure pushes the blood through the blockage.  
 
The lack and burst of oxygen in I/R cycles are associated with elevated levels of reactive oxygen 
species (ROS) that are thought to compromise the bioenergetics of the mitochondria, damaging it 
and further releasing ROS in “ROS-induced-ROS” positive feedback loop8,12,13. During ischemia, 
XO is the primary source of ROS, releasing O2˙
- during the conversion of hypoxanthine to 
xanthine13. The high oxygen supply at the beginning of reperfusion activates several sources 
(xanthine oxidase, p66Shc, mitochondrial KATP channels, and monoamine oxidases, among others) 
of ROS (mainly O2˙
-, H2O2, HO˙, NO, and peroxynitrite)
13-16. Thus, the primary sources of ROS 




The resulting chronically elevated ROS is believed to be one of the causes of ischemic muscle 
injury7,8,13. The goal of this experiment is to elucidate a more direct relationship between CLI and 
mitochondrial damage through examination of mitochondrial complex II (succinate 
dehydrogenase) and IV (cytochrome C oxidase) in mice with surgically induced CLI. The results 
are expected to become the basis for future research aimed at identifying specific mitochondrial 
malfunctions that lead to ROS induced muscle degeneration in PAD patients, providing grounds 




To test and confirm that CLI induces mitochondrial dysfunction, adult mice underwent surgeries 
to ligate and excise the left femoral arteries between the hip and the ankle. On day 7 and 14 (n = 
3), the mice were asphyxiated and the tibialis anterior (TA) muscles were harvested. The collected 
TA muscles were frozen in isomethylbutane cooled to viscous state by liquid nitrogen, freezing 
the muscle fibers in relaxed states. The frozen muscles were sectioned by cryostat (ThermoFisher 
CryoStar NX70) in 10 µm thickness, and serial sections were stained for Hematoxylin and Eosin 
(H&E), succinate dehydrogenase (SDH), and cytochrome C oxidase (COX). 
For analysis, three random areas from each sample muscle section were photographed (20X). On 
each image, the number of fibers that had the desired quality was counted and divided over the 
total number of fibers in the image, leaving out fibers that are hard to quantify or and partially cut 
off by the image border. Using the right leg TA muscles as contralateral controls, the stained 
sections were compared for percentage of fibers with centralized nuclei (indication of muscle fiber 
regeneration) and the percentage of SDH+ and COX+ fibers. The quantified data was statistically 




Centralized Nuclei  
Originally, the centralized nuclei count data was only going to be compared within each sample 
(ex. Day 7 Mice 1’s left muscle data with Day 7 Mice 1’s right muscle data). However, two-way 
ANOVA showed no statistically significant differences (p>0.95) between the data from different 
mice of the same category. Based on this test, comparisons between the injured and the control 






The percentage of centralized nuclei showed significant differences between the Control and the 
Injured samples on both Day 7 and 14 (Figure 1). The percentage of centralized nuclei also showed 
statistically significant decrease in the Injured samples between Day 7 and 14 (Figure 1).  
 
Figure 2. Day 7 H&E stain images showing normal myofibers in 5X (A) and 20X (D). CLI injured 
myofibers are shown in 5X (B) and (C), and 20X (E) and (F). 
Figure 1. Percentage of fibers with centralized nuclei. Data are means ± SD, n=3 per day, 
**Tukey adjusted p<0.0001.  
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Day 7 H&E images showed considerable variation in the myofiber damage and regeneration 
between CLI injured mice samples (Figure 2). (B) and (E) are images from Mice #1 and (C) and 
(F) are from Mice #2. The images show much more new, purple muscle fibers with centralized 
nuclei in Mice #1 compared to Mice #2, which still show pink myofibers that are necrotizing (black 
arrow). 
Figure 3. Day 14 H&E stain images showing normal myofibers in 5X (A) and 20X (D). CLI injured 
myofibers are shown in 5X (B) and (C), and 20X (E) and (F). 
Day 14 images (Figure 3) showed less variation in myofiber damage and regeneration between 
CLI injured mice samples compared to Day 7 images (Figure 2). In Figure 3, (B) and (E) are from 
Mice # 4, and (C) and (F) are from Mice #5. Images from both Mice #4 and #5 still show a high 
concentration of centralized nuclei, but Mice #5 has extracellular matrix that is much more purple. 
This is most likely because not all of the myofiber fragmentation has been recovered, so some of 
the hematoxylin (purple staining for nuclei) leaked out. 
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The percentage of SDH+ fibers showed significant differences between the Control and the Injured 
samples on Day 7 (Figure 4). Day 14 data was not quantified due to technical difficulties (Figure 
6). 
Figure 5. Day 7 SDH stain images showing normal myofibers in 5X (A) and 20X (D). CLI injured 
myofibers are shown in 5X (B) and (C), and 20X (E) and (F). 
Day 7 SDH images (Figure 5) showed clear differences between control and CLI injured muscle 
sections. In Figure 5, (B) and (E) are images from Mice #1 and (C) and (F) are from Mice #2. Mice 
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Figure 4. Percentage of SDH+ fibers at Day 7. Data are means ± SD, n=3 per day, 
**Tukey adjusted p<0.005. 
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#1 show slightly more SDH+ fibers than Mice #2, which may correlate with the more advanced 
regeneration shown in Figure 2.  
Figure 6. Day 14 SDH stain images showing normal myofibers in 5X (A) and 20X (D). CLI injured 
myofibers are shown in 5X (B) and (C), and 20X (E) and (F). 
Day 14 SDH images (Figure 6) showed clear differences between control and CLI injured muscle 
sections. In Figure 6, (B) and (E) are images from Mice #4 and (C) and (F) are from Mice #5. The 
reason Day 14 SDH images were not quantified was because the outlines of muscle fibers 
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Figure 7. Day 7 COX stain images showing normal myofibers in 5X (A) and 20X (C). CLI injured 
myofibers are shown in 5X (B), and 20X (D). 
Day 7 COX images (Figure 7) showed very clear residues, mostly likely from the COX media that 
was stored at -4°C for about two weeks. Pilot tests of COX staining had used freshly made COX 
media and did not have this residue issue, but unfortunately, the Jang Lab ran out of the supply of 
cytochrome C oxidase, the main enzyme component for COX staining media. Because the residues 
would make quantifications very unreliable, COX stainings were not quantified and Day 14 




The goal of this experiment was to see how mitochondrial complex II (SDH) and IV (COX) are 
affected in mice with surgically induced critical limb ischemia. COX is a component of complex 
IV, which is encoded by both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA); it reflects 
respiratory chain function. SDH (complex II) is encoded by nDNA and is a sign of mitochondrial 
proliferation. The most relevant study was performed by Pipinos et al. where he measured the 
activity of mitochondrial complexes I through IV between control and PAD patients’ gastric 
muscle8. They found that all but complex II were significantly different8, while is seemingly 
different than what the data in this experiment indicates. While the SDH and COX data were not 
fully obtained and quantified in this experiment, the Day 7 COX images hint at higher percentages 
of COX+ fibers than SDH+ fibers. If additional experiments do show the abundance of such COX+ 
SDH- fibers commonly know as ragged red fibers (RRF), it will indicate at least partly functional 
electron transport chain and compromise in mitochondria’s ability to proliferate.  
Three main things could be improved from this experiment. First, several studies have concluded 
that oxidative damage is myofiber type selective, where type II fast twitch and type I/II fibers are 





used in this experiment, is primarily glyosidic, with mostly type II fibers on the exterior and some 
type I fibers on the interior. Such regional distribution pattern makes taking random area photos 
for quantification much less effective in sampling for the whole section. To account for the 
additional independent variable (fiber type), it will be very helpful for future experiments to couple 
SDH and COX staining with myosin heavy chain (MHC) staining to see if the addition of the 
variable shows any new distinct patterns.  
Second, to calculate fiber areas and to improve the quantifications of SDH and COX images, it 
will be very helpful to perform fluorescence staining of SDH and sarcolemma, as the SDH images 
from this experiment were difficult to accurately quantify because of the background noise and 
unidentifiable fiber outlines.  
Third, a standard or an algorithm to distinguish between positive and negative fibers in SDH and 
COX staining are needed, as this experiment simply excluded the fibers that are shades of light 
blue. Originally, the light intensity of blue color (for SDH) and brown color (for COX) was going 
to be analyzed to distinguish between the positive and negative fibers in each staining. However, 
each section requires different amount of light intensity adjustment on the microscope to get the 
best image, so the base light intensity is not consistent across the different sections and samples. 
For this experiment, the images were quantified by hand, leaving much room for improvements in 
accuracy and precision.  
In conclusion, although this study was not able to derive conclusive data, it offers multiple points 
that could be improved in follow up experiments. Such future experiments will contribute to an 
understanding of the underlying biochemical mechanism through which mitochondrial 
bioenergetics is compromised by oxidative damage, providing grounds for developing targeted 
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